Physician profile
John K Cordero
NPI 1629538111
$10,382.71
in general payments reported to CMS, 2019-2025
8 companies · $9,565 in 2025
The $9,565 reported for 2025 was more than what 76% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $818 · 2025: $9,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,719 · Food and Beverage: $4,461 · Education: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,719.39 |
| Food and Beverage | $4,461.10 |
| Education | $1,202.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,989.96 | 2024-2025 | Avenir, Persona, Oxford |
| Smith+Nephew, INC. | $2,855.39 | 2025 | Journey II, Legion Revision, Polarcup |
| Stryker Corporation | $1,706.23 | 2025 | Mako, T2 Alpha |
| Medacta USA, INC. | $1,212.74 | 2025 | Gmk Sphere |
| Medical Device Business Services, INC. | $1,169.33 | 2025 | Actis, Reclaim |
| Linkbio Corp | $230.93 | 2025 | |
| Depuy Synthes Sales INC. | $146.99 | 2025 | Velys |
| Davol INC. | $71.14 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cordero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.